Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhibitors for Treating Patients? What Have We Learned From The PARADIGM and PARAGON Trials? | VuMedi

San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhibitors for Treating Patients? What Have We Learned From The PARADIGM and PARAGON Trials?

By San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians FEATURING Barry Greenberg

By San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians FEATURING Barry Greenberg

2,019 views

February 5, 2021

Comments 0

Login to view comments. Click here to Login